非典型脑膜瘤次全切除术后辅助放射外科与连续监测的系统分析
该系统分析纳入619例非典型脑膜瘤次全切除患者,比较辅助放射外科(ARS,263例)与连续监测(SS,356例)的结局;ARS组平均复发率53.5%、5年无进展生存率50.3%、5年总生存率74.9%,SS组分别为89.8%、19.1%、89.8%;ARS与SS间复发率和5年无进展生存率存在显著差异,提示ARS可能获益。
要点
- ARS组平均复发率53.5% vs SS组89.8%,两组间差异有统计学意义(P < 0.001)。
- ARS组5年无进展生存率50.3% vs SS组19.1%,两组间差异有统计学意义(P < 0.001)。
- ARS组5年总生存率74.9% vs SS组89.8%,原文未报告两组间总生存率的统计学比较。
核心结论
- 数据表明ARS与SS在复发率和5年无进展生存率上存在显著差异,提示ARS可能获益。
- 随着对非典型脑膜瘤不同治疗策略临床结局认识的增加,将放射外科等模态整合进管理指南的目标更近一步。
研究设计与样本
- 系统分析,检索Embase、PubMed和Cochrane数据库,纳入描述非典型脑膜瘤次全切除后接受ARS或SS治疗的回顾性病例系列。
- 共纳入619例患者,其中ARS组263例、SS组356例;采用比例检验比较复发率、5年无进展生存率和5年总生存率。
主要发现
- ARS组平均复发率53.5% vs SS组89.8%,两组间差异有统计学意义(P < 0.001)。
- ARS组5年无进展生存率50.3% vs SS组19.1%,两组间差异有统计学意义(P < 0.001)。
- ARS组5年总生存率74.9% vs SS组89.8%,原文未报告两组间总生存率的统计学比较。
- 5年无进展生存率在ARS研究间(P = 0.007)及SS研究间(P < 0.001)也存在差异。
关键数值与推荐
- ARS组平均复发率53.5%、5年无进展生存率50.3%、5年总生存率74.9%。
- SS组平均复发率89.8%、5年无进展生存率19.1%、5年总生存率89.8%。
- 复发率在ARS与SS间及ARS研究间差异有统计学意义(P < 0.001)。
- 5年无进展生存率在ARS与SS间、ARS研究间(P = 0.007)、SS研究间(P < 0.001)差异有统计学意义。
临床怎么用
- 原文未据此给出推荐。
局限性
- 纳入的研究为回顾性病例系列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atypical meningioma (AM) is an aggressive subtype of meningioma associated with a high recurrence rates (RR) following surgical resection. Recent studies have compared outcomes of various treatment strategies, but advantages of adjuvant radiosurgery (ARS) over serial surveillance (SS) following subtotal resection (STR) remain unclear. To further elucidate this issue, we systematically analyzed the current literature on AM and compared outcomes of ARS versus SS after STR. METHODS: Embase, PubMed, and Cochrane databases were queried using relevant search terms. Retrospective case series that described patients with AM treated with ARS and SS after STR were included. Tests of proportions were performed to detect significant variations in RR, 5-year progression-free survival (PFS), and 5-year overall survival (OS) between the treatment strategies (ARS vs. SS) and among individual studies. RESULTS: A total of 619 patients (263 in the ARS group and 356 in the SS group) were identified. Mean RR, 5-year PFS, and 5-year OS were 53.5%, 50.3%, and 74.9%, respectively, for ARS versus 89.8%, 19.1%, and 89.8% for SS. RR differed between treatment strategies and ARS studies (P < 0.001), and 5-year PFS differed among treatment strategies, ARS, and SS studies (P < 0.001, P = 0.007, and P < 0.001, respectively). CONCLUSIONS: The data presented here show significant differences in RR and 5-year PFS between ARS and SS, suggesting a potential benefit of ARS. As our understanding of the clinical outcomes of various treatment strategies for AM increases, we also move closer to integrating modalities, such as radiosurgery, into management guidelines.
引用
- Lagman C, Bhatt NS, Lee SJ, et al. Adjuvant Radiosurgery Versus Serial Surveillance Following Subtotal Resection of Atypical Meningioma: A Systematic Analysis. World Neurosurg. 2016. PMID: 27856384. doi:10.1016/j.wneu.2016.11.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。